Around half of the respondents (50.9%) were with a cluster of differentiation 4 (CD4) count less than 500 cells/μL. More than three-fourth (78.4%) of the participants were in the World Health Organization (WHO) stage I, and among the participants, 11.1% (n = 47) had a history of comorbid tuberculosis. Here, CD4 is linked to tuberculosis.